View Author
scopus: 36088815400

Jacobs, R.J.

(Rutger J. Jacobs)


cancer hct 116 cells lovastatin statin promoter crc cells bmp 2 promoter bmp 2 treatment expression methylation methylated differentiation 2 mm lovastatin colorectal cancer effect colorectal bmp 2 expression colon study control pathway protein bmp pathway analysis marker concentration region xenograft level lovastatin treatment patient cell lines demethylation activity phenotype agent netherland 5- fu unmethylated tumour island gut.bmj.com gastroenterology hypermethylation xenograft mouse model dna methylation hct 116 xenografts colon cancer cells suppressor dnmt activity inhibitor november downloaded group.bmj.com assay cancer therapy model simvastatin 1553. 5 days result therapy promoter hypermethylation bmp 2 methylation villin unmethylated cpg sites crc cell lines stemnes transcription pcr analysis mutation demethylating goblet cell differentiation speci goblet methyltransferase leiden university statin treatment transcription dnmt inhibitors




1 Most Recent Publications

Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway (Article)
Kodach, L.L. Jacobs, R.J. Hardwick, J.C.H. Voorneveld, P.W. Wildenberg, M.E. Verspaget, H.W. Wezel, T. van Morreau, H. Hommes, D.W. Peppelenbosch, M.P. Brink, G.R. van den
2011-11-01